613 related articles for article (PubMed ID: 16456024)
21. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.
Ricciardelli I; Lindley KJ; Londei M; Quaratino S
Immunology; 2008 Oct; 125(2):178-83. PubMed ID: 18422560
[TBL] [Abstract][Full Text] [Related]
22. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.
Ramirez SH; Fan S; Dykstra H; Reichenbach N; Del Valle L; Potula R; Phipps RP; Maggirwar SB; Persidsky Y
J Neurosci; 2010 Jul; 30(28):9454-64. PubMed ID: 20631174
[TBL] [Abstract][Full Text] [Related]
23. CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.
Stokes KY; Calahan L; Hamric CM; Russell JM; Granger DN
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H689-97. PubMed ID: 19112095
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor-alpha production stimulated by heat shock protein 70 and its inhibition in circulating dendritic cells and cells eluted from mucosal tissues in Crohn's disease.
Whittall T; Wang Y; Kelly CG; Thompson R; Sanderson J; Lomer M; Soon SY; Bergmeier LA; Singh M; Lehner T
Clin Exp Immunol; 2006 Mar; 143(3):550-9. PubMed ID: 16487255
[TBL] [Abstract][Full Text] [Related]
25. Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease.
Kirman I; Whelan RL; Nielsen OH
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):639-41. PubMed ID: 15201575
[TBL] [Abstract][Full Text] [Related]
26. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
[TBL] [Abstract][Full Text] [Related]
27. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
Ludwiczek O; Kaser A; Tilg H
Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
[TBL] [Abstract][Full Text] [Related]
30. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes.
Kotowicz K; Dixon GL; Klein NJ; Peters MJ; Callard RE
Immunology; 2000 Aug; 100(4):441-8. PubMed ID: 10929070
[TBL] [Abstract][Full Text] [Related]
31. CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent.
Kojok K; Akoum SE; Mohsen M; Mourad W; Merhi Y
J Am Heart Assoc; 2018 Dec; 7(23):e03677. PubMed ID: 30571597
[TBL] [Abstract][Full Text] [Related]
32. Effect of CD40--CD40 ligand interaction on diacylglycerol-protein kinase C and inositol trisphosphate-Ca(2+) signal transduction pathway in human umbilical vein endothelial cells.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2003 Nov; 337(1-2):133-40. PubMed ID: 14568189
[TBL] [Abstract][Full Text] [Related]
33. Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation with no effect of aspirin intake.
Giannini S; Falcinelli E; Bury L; Guglielmini G; Rossi R; Momi S; Gresele P
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2072-9. PubMed ID: 21378140
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
[TBL] [Abstract][Full Text] [Related]
35. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
Kalinichenko TV; Mokyr MB
Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
[TBL] [Abstract][Full Text] [Related]
36. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.
Reul RM; Fang JC; Denton MD; Geehan C; Long C; Mitchell RN; Ganz P; Briscoe DM
Transplantation; 1997 Dec; 64(12):1765-74. PubMed ID: 9422418
[TBL] [Abstract][Full Text] [Related]
37. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression.
Miller DL; Yaron R; Yellin MJ
J Leukoc Biol; 1998 Mar; 63(3):373-9. PubMed ID: 9500526
[TBL] [Abstract][Full Text] [Related]
38. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin MJ; Brett J; Baum D; Matsushima A; Szabolcs M; Stern D; Chess L
J Exp Med; 1995 Dec; 182(6):1857-64. PubMed ID: 7500031
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment.
Liu MF; Chao SC; Wang CR; Lei HY
Autoimmunity; 2001; 34(2):107-13. PubMed ID: 11905840
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury.
Tuinman PR; Gerards MC; Jongsma G; Vlaar AP; Boon L; Juffermans NP
Clin Exp Immunol; 2011 Aug; 165(2):278-84. PubMed ID: 21605114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
